Logo

Dermatophytic Onychomycosis Therapeutics Market Size, Share, and Growth Forecast 2026 - 2033

Dermatophytic Onychomycosis Therapeutics Market by Treatment Type (Drug-Based Treatment, Laser Therapy, Photodynamic Therapy, Combination Therapy), Indication, End-user (Institutional Sales, Retail Sales), by Regional Analysis, 2026 - 2033

ID: PMRREP5840
Calendar

June 2026

282 Pages

Author : Abhijeet Surwase

Healthcare
  1. Executive Summary
    1. Global Dermatophytic Onychomycosis Therapeutics Market Snapshot 2026 and 2033
    2. Market Opportunity Assessment, 2026-2033, US$ Bn
    3. Key Market Trends
    4. Industry Developments and Key Market Events
    5. Demand Side and Supply Side Analysis
    6. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definitions
    2. Value Chain Analysis
    3. Macro-Economic Factors
      1. Global GDP Outlook
      2. Global Sectorial Outlook
      3. Global GDP Growth Outlook
    4. Forecast Factors - Relevance and Impact
    5. COVID-19 Impact Assessment
    6. PESTLE Analysis
    7. Porter's Five Forces Analysis
    8. Geopolitical Tensions: Market Impact
    9. Regulatory and Technology Landscape
  3. Market Dynamics
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Trends
  4. Global Dermatophytic Onychomycosis Therapeutics Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. Global Dermatophytic Onychomycosis Therapeutics Market Outlook: Treatment Type
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by Treatment Type, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by Treatment Type, 2026-2033
        1. Drug-Based Treatment
          1. Topical Antifungals
          2. Oral Antifungals
        2. Laser Therapy
        3. Photodynamic Therapy
        4. Combination Therapy
      4. Market Attractiveness Analysis: Treatment Type
    3. Global Dermatophytic Onychomycosis Therapeutics Market Outlook: Indication
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by Indication, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by Indication, 2026-2033
        1. Distal Subungual Onychomycosis
        2. White Superficial Onychomycosis
        3. Proximal Subungual Onychomycosis
        4. Candidal Onychomycosis
        5. Total Dystrophic Onychomycosis
      4. Market Attractiveness Analysis: Indication
    4. Global Dermatophytic Onychomycosis Therapeutics Market Outlook: End-user
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by End-user, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by End-user, 2026-2033
        1. Institutional Sales
          1. Hospitals
          2. Dermatology Clinics
        2. Retail Sales
          1. Retail Pharmacies
          2. Drug Stores
          3. Mail Order Pharmacies & Online Sales
      4. Market Attractiveness Analysis: End-user
  5. Global Dermatophytic Onychomycosis Therapeutics Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis by Region, 2020-2025
    3. Current Market Size (US$ Bn) Forecast by Region, 2026-2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia & Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Dermatophytic Onychomycosis Therapeutics Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. North America Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. U.S.
      2. Canada
    3. North America Market Size (US$ Bn) Forecast, by Treatment Type, 2026-2033
      1. Drug-Based Treatment
        1. Topical Antifungals
        2. Oral Antifungals
      2. Laser Therapy
      3. Photodynamic Therapy
      4. Combination Therapy
    4. North America Market Size (US$ Bn) Forecast, by Indication, 2026-2033
      1. Distal Subungual Onychomycosis
      2. White Superficial Onychomycosis
      3. Proximal Subungual Onychomycosis
      4. Candidal Onychomycosis
      5. Total Dystrophic Onychomycosis
    5. North America Market Size (US$ Bn) Forecast, by End-user, 2026-2033
      1. Institutional Sales
        1. Hospitals
        2. Dermatology Clinics
      2. Retail Sales
        1. Retail Pharmacies
        2. Drug Stores
        3. Mail Order Pharmacies & Online Sales
  7. Europe Dermatophytic Onychomycosis Therapeutics Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. Europe Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. Germany
      2. Italy
      3. France
      4. U.K.
      5. Spain
      6. Russia
      7. Rest of Europe
    3. Europe Market Size (US$ Bn) Forecast, by Treatment Type, 2026-2033
      1. Drug-Based Treatment
        1. Topical Antifungals
        2. Oral Antifungals
      2. Laser Therapy
      3. Photodynamic Therapy
      4. Combination Therapy
    4. Europe Market Size (US$ Bn) Forecast, by Indication, 2026-2033
      1. Distal Subungual Onychomycosis
      2. White Superficial Onychomycosis
      3. Proximal Subungual Onychomycosis
      4. Candidal Onychomycosis
      5. Total Dystrophic Onychomycosis
    5. Europe Market Size (US$ Bn) Forecast, by End-user, 2026-2033
      1. Institutional Sales
        1. Hospitals
        2. Dermatology Clinics
      2. Retail Sales
        1. Retail Pharmacies
        2. Drug Stores
        3. Mail Order Pharmacies & Online Sales
  8. East Asia Dermatophytic Onychomycosis Therapeutics Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. East Asia Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. China
      2. Japan
      3. South Korea
    3. East Asia Market Size (US$ Bn) Forecast, by Treatment Type, 2026-2033
      1. Drug-Based Treatment
        1. Topical Antifungals
        2. Oral Antifungals
      2. Laser Therapy
      3. Photodynamic Therapy
      4. Combination Therapy
    4. East Asia Market Size (US$ Bn) Forecast, by Indication, 2026-2033
      1. Distal Subungual Onychomycosis
      2. White Superficial Onychomycosis
      3. Proximal Subungual Onychomycosis
      4. Candidal Onychomycosis
      5. Total Dystrophic Onychomycosis
    5. East Asia Market Size (US$ Bn) Forecast, by End-user, 2026-2033
      1. Institutional Sales
        1. Hospitals
        2. Dermatology Clinics
      2. Retail Sales
        1. Retail Pharmacies
        2. Drug Stores
        3. Mail Order Pharmacies & Online Sales
  9. South Asia & Oceania Dermatophytic Onychomycosis Therapeutics Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. South Asia & Oceania Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of SAO
    3. South Asia & Oceania Market Size (US$ Bn) Forecast, by Treatment Type, 2026-2033
      1. Drug-Based Treatment
        1. Topical Antifungals
        2. Oral Antifungals
      2. Laser Therapy
      3. Photodynamic Therapy
      4. Combination Therapy
    4. South Asia & Oceania Market Size (US$ Bn) Forecast, by Indication, 2026-2033
      1. Distal Subungual Onychomycosis
      2. White Superficial Onychomycosis
      3. Proximal Subungual Onychomycosis
      4. Candidal Onychomycosis
      5. Total Dystrophic Onychomycosis
    5. South Asia & Oceania Market Size (US$ Bn) Forecast, by End-user, 2026-2033
      1. Institutional Sales
        1. Hospitals
        2. Dermatology Clinics
      2. Retail Sales
        1. Retail Pharmacies
        2. Drug Stores
        3. Mail Order Pharmacies & Online Sales
  10. Latin America Dermatophytic Onychomycosis Therapeutics Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. Latin America Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. Brazil
      2. Mexico
      3. Rest of LATAM
    3. Latin America Market Size (US$ Bn) Forecast, by Treatment Type, 2026-2033
      1. Drug-Based Treatment
        1. Topical Antifungals
        2. Oral Antifungals
      2. Laser Therapy
      3. Photodynamic Therapy
      4. Combination Therapy
    4. Latin America Market Size (US$ Bn) Forecast, by Indication, 2026-2033
      1. Distal Subungual Onychomycosis
      2. White Superficial Onychomycosis
      3. Proximal Subungual Onychomycosis
      4. Candidal Onychomycosis
      5. Total Dystrophic Onychomycosis
    5. Latin America Market Size (US$ Bn) Forecast, by End-user, 2026-2033
      1. Institutional Sales
        1. Hospitals
        2. Dermatology Clinics
      2. Retail Sales
        1. Retail Pharmacies
        2. Drug Stores
        3. Mail Order Pharmacies & Online Sales
  11. Middle East & Africa Dermatophytic Onychomycosis Therapeutics Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. Middle East & Africa Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. GCC Countries
      2. South Africa
      3. Northern Africa
      4. Rest of MEA
    3. Middle East & Africa Market Size (US$ Bn) Forecast, by Treatment Type, 2026-2033
      1. Drug-Based Treatment
        1. Topical Antifungals
        2. Oral Antifungals
      2. Laser Therapy
      3. Photodynamic Therapy
      4. Combination Therapy
    4. Middle East & Africa Market Size (US$ Bn) Forecast, by Indication, 2026-2033
      1. Distal Subungual Onychomycosis
      2. White Superficial Onychomycosis
      3. Proximal Subungual Onychomycosis
      4. Candidal Onychomycosis
      5. Total Dystrophic Onychomycosis
    5. Middle East & Africa Market Size (US$ Bn) Forecast, by End-user, 2026-2033
      1. Institutional Sales
        1. Hospitals
        2. Dermatology Clinics
      2. Retail Sales
        1. Retail Pharmacies
        2. Drug Stores
        3. Mail Order Pharmacies & Online Sales
  12. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
      1. Competition Intensity Mapping
      2. Competition Dashboard
    3. Company Profiles
      1. Bausch Health
        1. Company Overview
        2. Product Portfolio/Offerings
        3. Key Financials
        4. SWOT Analysis
        5. Company Strategy and Key Developments
      2. Galderma S.A.
      3. Novartis AG
      4. Pfizer, Inc.
      5. Moberg Pharma AB
      6. Bayer AG
      7. Dr. Reddy’s Laboratories Ltd.
      8. Cipla Ltd.
      9. Medimetriks Pharmaceuticals, Inc.
      10. Sanofi S.A.
      11. GlaxoSmithKline Plc.
      12. Teva Pharmaceutical Industries Ltd.
      13. Cardinal Health Inc.
      14. Viatris Inc.
      15. Others
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
Emailsales@persistencemarketresearch.com
UK

Corporate Office

Persistence Research & Consultancy Services Limited

Company Number : 15310893

Second Floor, 150 Fleet Street,London, EC4A 2DQ.

+44 203-837-5656
USA

Regional Office

Persistence Market Research

108 W 39th Street, Ste 1006,PMB2219, New York, NY 10018

+1 646-878-6329
India

Global Research centre

Persistence Market Research Private Limited

CIN : U74900PN2014PTC153163

IT Unit No. 504, 5th Floor, IconTower, Baner, Pune - 411045.

+91 906 779 3500SIN : +65 6531 3894 98
Quick Links
CareersTerms & ConditionsReturn PolicyMarket Research Report
Customer FAQ’sPrivacy PolicySitemap

Copyright © 2026 Persistence Market Research. All Rights Reserved

Connect With Us -